| VANDA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US9216591084 / A0JJT3 |
| VM4 (Frankfurt) / VNDA (NASDAQ) |
| FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA |
| - |
| https://www.vandapharma.c.. |
|
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapies addressing high unmet medical needs in areas such as sleep-wake disorders, psychiatric and neurologic conditions, motion sickness,..
>Volltext.. |
| 305.16 Mio. EUR |
| 141.25 Mio. EUR |
| 188.27 Mio. EUR |
| -127 Mio. EUR |
| -207.08 Mio. EUR |
| -3.5 EUR |
| 11.3 Mio. EUR |
| 46.71 Mio. EUR |
| -109.37 Mio. EUR |
| 1.49 |
| 1.28% |
| -406.92% |
| - |
| - |
| - |
| - |
| VANDA |
| 15.06.26 |
|